Stocks analysis

Analysis for GL

$167.59 +0.18 (+0.11%)
  • 📈 Growth — 26/30
  • 💰 Profitability — 16/20
  • 🏦 Financial Health — 16/20
  • 💵 Valuation — 14/20
  • ⚠️ Risk — 4/10
Overall Score: 78/100

Summary:


📈 Growth & Financial Trajectory

Across 8 quarters, Revenues rose from about $1.46B (2024 Q3) to about $1.60B (2026 Q2), a cumulative gain near 9%. Net income (to parent) moved from roughly $255M in 2024 Q3 to about $288M in 2026 Q2, despite quarterly volatility (notably a spike in 2024 Q4). The trend shows durable top-line growth with improving scale and earnings power toward the latest quarter.

💰 Margins & Cash Flow

Gross margin traced to the mid-20s percent; for example, Q4 2025 shows gross_profit around $379.15M on $1.466B in revenues (~26%). Operating cash flow remained robust, with quarterly cash from operating activities typically in the $300M–$430M range; Q1 2026 was about $421M, Q2 2026 about $314M, and similar levels seen in other periods. Investing outflows are meaningful, but operating cash generation supports steady liquidity; free cash flow remains positive though variability exists due to investing activity.

🛡️ Balance Sheet & Liquidity

Assets run roughly $29.8B–$31.6B, with Liabilities around $24.3B–$25.4B and Equity in the $5.9B–$6.2B range. The liabilities base is substantial but comfortably offset by a solid equity cushion, yielding current ratios near 1.2–1.3 in several periods. This profile supports ongoing solvency and liquidity for operations and capital needs.

⚠️ Key Drivers & Risks

  • Drivers: Demand for life/annuity products and stable policyholder cash flows; favorable pricing/mix aiding resilience.
  • Risks: Interest-rate sensitivity and regulatory environment; valuation sensitivity to rate shifts and capital requirements.

📊 Key Financial Fundamentals

Valuation Multiples
Market Cap $13.29B
P/E Ratio 10.97
Forward P/E 11.32
P/S Ratio 2.15
P/B Ratio 2.25
EV / EBITDA 9.76
Profitability & Returns
Gross Margin N/A
Operating Margin 26.44%
Net Margin 19.58%
ROE 20.28%
ROIC 13.87%
Financial Health & Liquidity
Current Ratio 0.70
Quick Ratio 0.70
Financial Scale & Cash Flow
Revenue $6.19B
Net Income $1.21B
FCF Yield 9.27%
Free Cash Flow $1.23B
Total Debt To Equity 0.48